The developments of ILP100 as a new-to-the world drug candidate in cell-and gene therapy featured in Authority Magazine
In press
Immunology week hosted by Swedish TV
Immunology week hosted by Swedish TV, Malou efter 10. Mia Phillipson, Professor in physiology at Uppsala University and co-founder of Ilya Pharma gives an update of what immune cells do in the body during homeostasis and how they heal wounds in skin and mucosa. In Swedish.
Co-founder of Ilya Pharma shortlisted for pioneering achievements in bringing game-changing innovation to clinical proof of concept.
Twenty-one of the most talented and inspiring women entrepreneurs in Europe and beyond are in the shortlist for the EU Prize for Women Innovators 2020. The prize celebrates the outstanding achievements of female entrepreneurs running innovative companies and is funded by the EU’s Horizon 2020 programme for research and innovation. This year’s finalists are pioneering game-changing innovations across a wide range of industries and help combat global challenges. The winners of the EU Prize for Women Innovators 2020 will be announced at the European Research and Innovation Days taking place on 22-24 September 2020. At the same event, the Commission will award the European Capital of Innovation 2020, the EIC Horizon Prize for Affordable High-Tech for Humanitarian Aid, and the Horizon Impact Award 2020.
Ilya Pharma Awarded 5.3 million EUR
Life Science Sweden recognizes Ilya Pharma
Ilya Pharma selected for Springboard’s Health Innovation Hub
Ilya Pharma joins the ranks of globally recognized brands including Rebiotix, later acquired by Ferring, the first company in microbiome to recruit to a phase III trial. About Springboard Enterprises: Springboard Enterprises' mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. Since 2000, over 800 Springboard portfolio companies seeking investment of financial and human capital for product development and expansion have created $20 Billion in value via equity investments, 20 IPOs and 200 acquisitions by strategic partners. Springboard entrepreneurs are transforming industries.